Literature DB >> 3861628

Immunosuppression: a cause of porokeratosis?

J S Lederman, A J Sober, G S Lederman.   

Abstract

Two patients are reported in which the development of porokeratosis occurred following chemotherapy for systemic malignancy. Immunosuppression associated with malignancy and chemotherapy may exacerbate or initiate the development of porokeratosis in patients predisposed to alterations of cutaneous growth dynamics.

Entities:  

Mesh:

Year:  1985        PMID: 3861628     DOI: 10.1016/s0190-9622(85)70146-6

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  2 in total

1.  Atypical porokeratosis developing following bone marrow transplantation in a patient with myelodysplastic syndrome.

Authors:  Sang Hee Cha; Hyun Jeong Park; Jun Young Lee; Baik Kee Cho
Journal:  Ann Dermatol       Date:  2010-05-18       Impact factor: 1.444

2.  Porokeratosis of Mibelli in an immunosuppressed patient.

Authors:  F M Tatnall; I Sarkany
Journal:  J R Soc Med       Date:  1987-03       Impact factor: 18.000

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.